Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV
Pharma
GSK allows generic versions of cabotegravir for HIV treatment
GSK has expanded its agreement with the Medicines Patent Pool, allowing generic production of cabotegravir as an HIV treatment in poorer nations.
Kevin Dunleavy
Jul 15, 2025 2:16pm
Gilead enlists Global Fund in access campaign for new PrEP med
Jul 9, 2025 4:42pm
Fierce Healthcare
Judge sides with states, blocking HHS reorg and mass layoffs
Jul 1, 2025 3:30pm
Uptake of Gilead's Yeztugo will be swift, analyst says
Jun 25, 2025 2:51pm
With FDA nod, Gilead adds twice-yearly option to PrEP landscape
Jun 18, 2025 2:32pm
Gilead inks $202M deal to resolve long-running kickbacks case
Apr 29, 2025 4:15pm